Trials / Completed
CompletedNCT00503386
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting
A Phase II,Multicenter,Randomized,Double-blind,Cross-over Study of Palonosetron Compared With Granisetron in Prevention of Chemotherapy-induced Nausea and Vomiting in Asian Population
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Hangzhou Jiuyuan Gene Engineering Co. Ltd., · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether palonosetron is tolerate and effective in preventing chemotherapy-induced nausea and vomiting in oriental population. The study is comparing the safety and efficacy of palonosetron with granisetron, a frequently used antiemetic in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Palonosetron | |
| DRUG | Granisetron |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2007-07-18
- Last updated
- 2010-09-17
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00503386. Inclusion in this directory is not an endorsement.